Novo Nordisk will advance its acquired ATTR amyloidosis with cardiomyopathy monoclonal antibody (mAb) to Phase III trials. The Danish pharma said that the Phase II trial of coramitug (PRX004), an mAb ...

President Trump plans tariffs of up to 250% on imported drugs to boost U.S. pharmaceutical manufacturing. While aimed at reshoring production, the proposal sparks industry concerns over rising costs ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Driven by lessons from the pandemic and a reliance on imports -- more than $2.16 billion in packaged medicines in 2023, most ...

Ahead of President Donald Trump's so-called "Liberation Day" tariffs, more tariffs on Brazil and India are taking effect ...

After beating AstraZeneca’s Calquence in quarterly revenue for the first time at the end of 2024, BeOne Medicines’ Brukinsa ...

RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...

President Donald Trump plans to start with a “small tariff” on pharmaceutical imports before ramping duties up to 250% within ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Ocular Therapeutix, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Kennedy said Tuesday that the terminated contracts were worth nearly $500 million. Among them is an award to the University ...

For 2025, Charles River reduced its net income projection to a range between $4.25 and $4.65 a share from a prior per-share target of $4.35 to ...

In the second part of his Pharma Commerce video interview, Philip Sclafani, PwC's pharmaceutical and life sciences lead, ...